Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma, sold NAMS on Jun 22, 2026
Data as of Oct 16
▼ SELL$9.2K300 shares at $30.73Louise Frederika Kooij Chief Accounting OfficerNAMS NewAmsterdam Pharma Co N.V.
- Traded
- Jun 22, 2026
- Disclosed
- Jun 24, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
NAMS since disclosure
−39.2%
after the sale
Similar stocks (XLV) since disclosure
+15.2%
XLV — its sector index fund
Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLLouise Frederika Kooij Chief Accounting OfficerNAMS NewAmsterdam Pharma Co N.V.$1.2Mdisclosed Jun 24 · filed 2 days after the trade